Chicago Capital Management, LLC
13F Reported Value
ⓘ$112.3M
Holdings
27
Latest Filing
2026-06-30
Filing Quarter
Q2 2026
Portfolio Overview
Chicago Capital Management, LLC disclosed 27 positions worth $112.3M in its Form 13F-HR for Q2 2026, led by $NUVL (Nuvalent, Inc.) at 9.8% of the equity portfolio, followed by $APGE and $GTLS. During the quarter the fund opened 13 new positions and exited 16 — including a new stake in $NUVL and a full exit from $JHG. The portfolio is most concentrated in Technology (33.2% of disclosed assets). All figures are sourced directly from Chicago Capital Management, LLC’s Form 13F-HR filing with the SEC under CIK 1580162.
AI Fund Analysis
ConcentratingSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q2 2026
Click any card to unlockTop Holdings
- —
Quality
$11.1M115,500 sh - —
Quality
$9.8M97,100 sh - 49.0#1,684
Quality
$8.4M53,000 sh - 49.4
Quality
$7.6M8,153 sh - 51.8
Quality
$7.2M133,000 sh - 49.7
Quality
$7.1M6,904 sh - 48.3
Quality
$6.3M6,520 sh - 24.0
Quality
$5.9M6,068 sh - 11.0
Quality
$5.4M5,500 sh AMPHASTAR PHARMACEUTICALS IN - NOTE 2.000% 3/1
—Quality
$5.0M5,440 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
 Nuvalent, Inc.$NUVL | — | $11.1M | 115,500 |
 Apogee Therapeutics, Inc.$APGE | — | $9.8M | 97,100 |
 CHART INDUSTRIES INC$GTLS | 49.0#1,684 | $8.4M | 53,000 |
 Bandwidth Inc.$BAND | 49.4 | $7.6M | 8,153 |
 Taylor Morrison Home Corp$TMHC | 51.8 | $7.2M | 133,000 |
 Sabre Corp$SABR | 49.7 | $7.1M | 6,904 |
 Rapid7, Inc.$RPD | 48.3 | $6.3M | 6,520 |
 MGP INGREDIENTS INC$MGPI | 24.0 | $5.9M | 6,068 |
 Veritone, Inc.$VERI | 11.0 | $5.4M | 5,500 |
| AMPHASTAR PHARMACEUTICALS IN - NOTE 2.000% 3/1 | — | $5.0M | 5,440 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Chicago Capital Management, LLC's 27 positions.
Showing top 10 of 27 holdings.
Sector Allocation
Technology
$37.3M
Healthcare
$31.4M
Industrials
$19.5M
Other
$13.6M
Consumer Staples
$5.9M
Consumer Discretionary
$4.0M
Financials
$646,220
Full Holdings — Chicago Capital Management, LLC (Q2 2026)
All 27 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | $NUVL | Nuvalent, Inc. | $11.1M | 9.8% | NEW | — |
| 2 | $APGE | Apogee Therapeutics, Inc. | $9.8M | 8.7% | NEW | — |
| 3 | $GTLS | CHART INDUSTRIES INC | $8.4M | 7.4% | +0% | 49 |
| 4 | $BAND | Bandwidth Inc. | $7.6M | 6.8% | +0% | 49.4 |
| 5 | $TMHC | Taylor Morrison Home Corp | $7.2M | 6.4% | NEW | 51.8 |
| 6 | $SABR | Sabre Corp | $7.1M | 6.3% | +16% | 49.7 |
| 7 | $RPD | Rapid7, Inc. | $6.3M | 5.6% | +44% | 48.3 |
| 8 | $MGPI | MGP INGREDIENTS INC | $5.9M | 5.3% | +1% | 24 |
| 9 | $VERI | Veritone, Inc. | $5.4M | 4.8% | +120% | 11 |
| 10 | — | AMPHASTAR PHARMACEUTICALS IN - NOTE 2.000% 3/1 | $5.0M | 4.4% | NEW | — |
| 11 | — | THE REALREAL INC - NOTE 1.000% 3/0 | $4.8M | 4.3% | +0% | — |
| 12 |  $FIVN | Five9, Inc. | $4.5M | 4.0% | NEW | 59.7 |
| 13 |  $SHAK | Shake Shack Inc. | $4.0M | 3.5% | +0% | 55.6 |
| 14 |  $ETSY | ETSY INC | $3.9M | 3.5% | +0% | 61.2 |
| 15 | — | HEWLETT PACKARD ENTERPRISE C - 7.625 MAND CONV | $3.8M | 3.4% | +0% | — |
| 16 |  $SRPT | Sarepta Therapeutics, Inc. | $3.0M | 2.7% | NEW | 47.3 |
| 17 |  $CPRX | CATALYST PHARMACEUTICALS, INC. | $2.9M | 2.6% | NEW | 74 |
| 18 |  $ALOT | AstroNova, Inc. | $2.8M | 2.5% | NEW | 45.9 |
| 19 |  $ESPR | Esperion Therapeutics, Inc. | $2.6M | 2.3% | NEW | 46.3 |
| 20 |  $TECH | BIO-TECHNE Corp | $2.0M | 1.8% | NEW | 58.9 |
| 21 |  $XRX | Xerox Holdings Corp | $1.4M | 1.3% | +0% | 44.8 |
| 22 |  $PAR | PAR TECHNOLOGY CORP | $1.1M | 1.0% | +0% | 38.9 |
| 23 |  $TBRG | TruBridge, Inc. | $685,785 | 0.6% | NEW | 51.1 |
| 24 |  $STEL | Stellar Bancorp, Inc. | $342,427 | 0.3% | NEW | 37.4 |
| 25 |  $EA | ELECTRONIC ARTS INC. | $309,200 | 0.3% | +0% | 62.9 |
| 26 |  $NSTS | NSTS Bancorp, Inc. | $303,793 | 0.3% | NEW | 42.6 |
| 27 | $XRX | Xerox Holdings Corp | $26,395 | 0.0% | NEW | 44.8 |
New Positions (13)
$NUVL Nuvalent, Inc.$11.1M$APGE Apogee Therapeutics, Inc.$9.8M$TMHC Taylor Morrison Home Corp$7.2M$FIVN Five9, Inc.$4.5M$SRPT Sarepta Therapeutics, Inc.$3.0M$CPRX CATALYST PHARMACEUTICALS, INC.$2.9M$ALOT AstroNova, Inc.$2.8M$ESPR Esperion Therapeutics, Inc.$2.6M$TECH BIO-TECHNE Corp$2.0M$TBRG TruBridge, Inc.$685,785$STEL Stellar Bancorp, Inc.$342,427$NSTS NSTS Bancorp, Inc.$303,793Exited Positions (16)
$JHG Janus Henderson Group Ltd.
$ACLX Arcellx, Inc.
$FOLD AMICUS THERAPEUTICS, INC.
$IRWD IRONWOOD PHARMACEUTICALS INC
$CBRL CRACKER BARREL OLD COUNTRY STORE, INC
$ARAY ACCURAY INC
$APLS Apellis Pharmaceuticals, Inc.
$TERN Terns Pharmaceuticals, Inc.
$NBR NABORS INDUSTRIES LTD
$LAR Lithium Argentina AG
$ASRT Assertio Holdings, Inc.
$DHIL DIAMOND HILL INVESTMENT GROUP INC
$BLFY Blue Foundry Bancorp
$THR Thermon Group Holdings, Inc.
$DAWN Day One Biopharmaceuticals, Inc.Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Chicago Capital Management, LLC including:
Track Chicago Capital Management, LLC's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Chicago Capital Management, LLC and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Chicago Capital Management, LLC
13F Pro is an AI hedge fund tracker and stock research platform. For Chicago Capital Management, LLC (SEC CIK: 1580162), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Chicago Capital Management, LLC's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.